8 companies

Showing 1–8 of 8 companies

Oxford Biomedica

OXB is a cell and gene therapy CDMO developing and manufacturing viral vectors, with process development, GMP manufacturing, analytics, quality and regulatory services across five facilities in the UK, France and the US.

Autolus Therapeutics

Autolus Therapeutics is a London-based biopharmaceutical company developing programmed T cell therapies for cancer and autoimmune diseases; its AUCATZYL CAR T therapy received FDA approval in November 2024.

Bicycle Therapeutics

Clinical-stage biopharmaceutical company founded in 2009 developing bicyclic peptide medicines for cancer and other diseases, headquartered in Cambridge, UK with operations in Lexington, Massachusetts.

Silence Therapeutics

Immunocore

BioNTech

BioNTech is a global biotechnology company, founded in 2008, developing mRNA and other immunotherapies for cancer and serious diseases, including the first approved COVID-19 mRNA vaccine with Pfizer.

Abivax

Abivax is a clinical-stage biotechnology company founded in 2013 in Paris, developing oral microRNA-based therapeutics for chronic inflammatory diseases, led by obefazimod in ulcerative colitis.